Lysosomes as a therapeutic target
SR Bonam, F Wang, S Muller - Nature reviews Drug discovery, 2019 - nature.com
Lysosomes are membrane-bound organelles with roles in processes involved in degrading
and recycling cellular waste, cellular signalling and energy metabolism. Defects in genes …
and recycling cellular waste, cellular signalling and energy metabolism. Defects in genes …
Progranulin as a therapeutic target in neurodegenerative diseases
Progranulin (PGRN, encoded by the GRN gene) plays a key role in the development,
survival, function, and maintenance of neurons and microglia in the mammalian brain. It …
survival, function, and maintenance of neurons and microglia in the mammalian brain. It …
Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes
Lysosomes require an acidic lumen between pH 4.5 and 5.0 for effective digestion of
macromolecules. This pH optimum is maintained by proton influx produced by the V-ATPase …
macromolecules. This pH optimum is maintained by proton influx produced by the V-ATPase …
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden… - Brain, 2017 - academic.oup.com
Mutations in the glucocerebrosidase gene (GBA), which cause Gaucher disease, are also
potent risk factors for Parkinson's disease. We examined whether a genetic burden of …
potent risk factors for Parkinson's disease. We examined whether a genetic burden of …
[HTML][HTML] Mitochondria–lysosome crosstalk: from physiology to neurodegeneration
Cellular function requires coordination between different organelles and metabolic cues.
Mitochondria and lysosomes are essential for cellular metabolism as major contributors of …
Mitochondria and lysosomes are essential for cellular metabolism as major contributors of …
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
DG Hernandez, X Reed… - Journal of …, 2016 - Wiley Online Library
Parkinson's disease is a common, progressive neurodegenerative disorder, affecting 3% of
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …
those older than 75 years of age. Clinically, Parkinson's disease (PD) is associated with …
Alpha-synuclein aggregation pathway in Parkinson's disease: current status and novel therapeutic approaches
M Vidović, MG Rikalovic - Cells, 2022 - mdpi.com
Following Alzheimer's, Parkinson's disease (PD) is the second-most common
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
neurodegenerative disorder, sharing an unclear pathophysiology, a multifactorial profile …
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
A Ciechanover, YT Kwon - Experimental & molecular medicine, 2015 - nature.com
Mammalian cells remove misfolded proteins using various proteolytic systems, including the
ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and …
ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and …
Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling
Reactive oxygen and nitrogen species change cellular responses through diverse
mechanisms that are now being defined. At low levels, they are signalling molecules, and at …
mechanisms that are now being defined. At low levels, they are signalling molecules, and at …
[HTML][HTML] Lysosomal cathepsins and their regulation in aging and neurodegeneration
Lysosomes and lysosomal hydrolases, including the cathepsins, have been shown to
change their properties with aging brain a long time ago, although their function was not …
change their properties with aging brain a long time ago, although their function was not …